Cocoa
As of the edition of 20 October 2026, Cocoa is a drug: marketed.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed
- Kind
- Unknown
- Brand name
- Alyostal Intrakutantest
- Approvals on record
- 4 in 4 regions
- Holder of the most recent approval
- Stallergenes
- Registered trials
- 4, 1 stopped early
- Disease areas
- Lungs and airways; Bones, joints and muscles; Ear, nose and throat; Immune system; Infections; Mental health
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 3 | 2 | 0 | 1 |
| Phase 4 | 1 | 1 | 0 | 0 |
| All trials | 4 |
Who ran its trials
| Company | Role | Years |
|---|---|---|
| Verifomics | Lead sponsor of trials | 2016 to now |